This company listing is no longer active
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Medlab Clinical Gelecekteki Büyüme
Future kriter kontrolleri 2/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Medlab Clinical.
Anahtar bilgiler
-44.7%
Kazanç büyüme oranı
-44.7%
EPS büyüme oranı
Biotechs kazanç büyümesi | 15.0% |
Gelir büyüme oranı | 41.7% |
Gelecekteki özkaynak getirisi | n/a |
Analist kapsamı | Low |
Son güncelleme | 04 May 2023 |
Gelecekteki son büyüme güncellemeleri
Recent updates
Shareholders May Be More Conservative With Medlab Clinical Limited's (ASX:MDC) CEO Compensation For Now
Oct 06Is Medlab Clinical (ASX:MDC) In A Good Position To Invest In Growth?
Oct 05What We Learned About Medlab Clinical's (ASX:MDC) CEO Pay
Feb 21Medlab Clinical (ASX:MDC) Share Prices Have Dropped 69% In The Last Three Years
Dec 30Medlab Clinical Limited (ASX:MDC) Is Expected To Breakeven In The Near Future
Nov 22Kazanç ve Gelir Büyüme Tahminleri
Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
---|---|---|---|---|---|
6/30/2024 | 4 | -22 | N/A | N/A | 1 |
6/30/2023 | 7 | -14 | N/A | N/A | 1 |
6/30/2022 | 2 | -8 | -9 | -9 | N/A |
3/31/2022 | 1 | -9 | -10 | -10 | N/A |
12/31/2021 | 4 | -12 | -11 | -11 | N/A |
9/30/2021 | 4 | -12 | -11 | -11 | N/A |
6/30/2021 | 1 | -10 | -10 | -10 | N/A |
3/31/2021 | 1 | -10 | -9 | -9 | N/A |
12/31/2020 | 1 | -11 | -8 | -8 | N/A |
9/30/2020 | 2 | -12 | -10 | -9 | N/A |
6/30/2020 | 3 | -13 | -11 | -10 | N/A |
3/31/2020 | 4 | -12 | -11 | -11 | N/A |
12/31/2019 | 4 | -12 | -12 | -12 | N/A |
9/30/2019 | 5 | -10 | -11 | -11 | N/A |
6/30/2019 | 5 | -8 | -11 | -10 | N/A |
3/31/2019 | 5 | -7 | -9 | -9 | N/A |
12/31/2018 | 5 | -6 | -7 | -7 | N/A |
9/30/2018 | 4 | -5 | -6 | -6 | N/A |
6/30/2018 | 4 | -5 | -5 | -5 | N/A |
3/31/2018 | 4 | -4 | -5 | -5 | N/A |
12/31/2017 | 5 | -4 | -5 | -5 | N/A |
9/30/2017 | 5 | -4 | -4 | -4 | N/A |
6/30/2017 | 4 | -4 | -4 | -4 | N/A |
3/31/2017 | 4 | -4 | -4 | -4 | N/A |
12/31/2016 | 4 | -4 | -4 | -4 | N/A |
9/30/2016 | 3 | -4 | -4 | -4 | N/A |
6/30/2016 | 3 | -3 | -4 | -4 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: MDC is forecast to remain unprofitable over the next 3 years.
Kazançlar ve Piyasa: MDC is forecast to remain unprofitable over the next 3 years.
Yüksek Büyüme Kazançları: MDC is forecast to remain unprofitable over the next 3 years.
Gelir ve Pazar: MDC's revenue (41.7% per year) is forecast to grow faster than the Australian market (4.8% per year).
Yüksek Büyüme Geliri: MDC's revenue (41.7% per year) is forecast to grow faster than 20% per year.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: Insufficient data to determine if MDC's Return on Equity is forecast to be high in 3 years time